Cover Image

Clinical utility of the treatment eligibility score HEPSANET for chronic hepatitis B in Asia

Saved in:

Bibliographic Details
Main Authors:	Jian Wang (Author), Zhiyi Zhang (Author), Chuanwu Zhu (Author), Chao Wu (Author), Rui Huang (Author)
Format:	Book
Published:	Elsevier, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chronic hepatitis B and D: prognosis according to Child-Pugh score
by: Marcelo Siqueira de Oliveira, et al.

Clinical utility of entecavir for chronic hepatitis B in Chinese patients
by: Wang JY
Published: (2013)

The impact of Dual Eligible Special Need Plan regulations on healthcare utilization
by: Kimberly Danae Cauley Narain, et al.
Published: (2021)

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B
by: Martin F. Sprinzl, et al.
Published: (2021)

Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States
by: Mondher Toumi, et al.
Published: (2024)

Health Care Utilization and Costs in Patients with Hepatitis B related Disease in Jiangsu, China
by: Hua Zhang, et al.
Published: (2015)

Molecular Epidemiology of Hepatitis B Virus in Pakistan: Link with Southern Asia
by: Saeeda Baig
Published: (2024)

Impact of low/no-charge coronary artery calcium scoring on statin eligibility and outcomes in women: The CLARIFY study
by: Sadeer Al-Kindi, et al.
Published: (2022)

Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B
by: Chao DC, et al.
Published: (2013)

Cost-utility analysis of newborn hepatitis B immunization in Beijing
by: Yiwei Guo, et al.
Published: (2021)

Health care utilization among Medicare-Medicaid dual eligibles: a count data analysis
by: Shin Jaeun, et al.
Published: (2006)

GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients
by: Clemens Schotten, et al.
Published: (2021)

Use of outpatient care in VA and Medicare among disability-eligible and age-eligible veteran patients
by: Liu Chuan-Fen, et al.
Published: (2012)

Risk of Hepatitis B Transmission After Amniocentesis in Chronic Hepatitis B Carriers
by: James M. Alexander, et al.
Published: (1999)

Hepatitis B knowledge and associated factors among people with chronic hepatitis B
by: Behzad Hajarizadeh, et al.
Published: (2015)

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
by: Kerui Xu, et al.
Published: (2018)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Yan Huang, et al.
Published: (2022)

Artemisinin: A Panacea Eligible for Unrestrictive Use?
by: Dong-Sheng Yuan, et al.
Published: (2017)

Is hepatitis B antigen in cord blood an immunotolerogen playing a critical role in the pathogenesis of chronic hepatitis B?
by: Hongyu Huang, et al.
Published: (2019)

Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs
by: L. Degli Esposti, et al.
Published: (2021)

The burden of cirrhosis and other chronic liver diseases due to hepatitis B in children and adolescents: results from global burden of disease study 2019
by: Chenyang Huang, et al.
Published: (2023)

Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C
by: P. Marrero-Álvarez, et al.
Published: (2014)

Medical eligibility criteria for contraceptive use
by: Ma. del Carmen Cravioto Galindo
Published: (2016)

Drafting eligible biotech and immunotherapy claims
by: Shyh-Jen Wang
Published: (2019)

Pediatric urology: Development, eligibility, practice
by: Bajpai M
Published: (2009)

A hepatitis B virus flare that led to hepatic decompensation and liver transplantation in a pregnant woman with chronic hepatitis B: a rare case report and literature review
by: Chih-Hsiang Yin, et al.
Published: (2022)

Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain
by: Antonio Aguilera, et al.
Published: (2018)

VITAMIN D LEVELS IN PATIENTS WITH CHRONIC HEPATITIS B, CHRONIC HEPATITIS C, AND HEALTH CONTROLS
by: Biljana Ilkovska, et al.
Published: (2019)

Clinical Feature of Intrahepatic B-Lymphocytes in Chronic Hepatitis B
by: Ashraf Mohamadkhani, et al.
Published: (2014)

TREATMENT FOR THE CHRONIC HEPATITIS B AMONG CHILDREN
by: T.V. Strokova, et al.
Published: (2007)

TREATMENT FOR THE CHRONIC HEPATITIS B AMONG CHILDREN
by: T.V. Strokova, et al.
Published: (2007)

Current characteristics of chronic hepatitis B in Egypt
by: Maha M Elsabaawy, et al.
Published: (2019)

Effects of Telbivudine Treatment on the Circulating CD4+ T-Cell Subpopulations in Chronic Hepatitis B Patients
by: Yanhua Zheng, et al.
Published: (2012)

Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission
by: Kailu Fang, et al.
Published: (2024)

Tratamiento para la infección por hepatitis B Crónica Treatmen for chronic hepatitis B infection
by: Sandra L Valderrama, et al.
Published: (2007)

Relationship between hepatitis B DNA Viral load in the liver and it\'s histology in patient with chronic hepatitis B
by: Tahmineh Biazar, et al.
Published: (2015)

Chronic hepatitis B and hepatitis D superinfection in patients in the brazilian Western Amazon.
by: Marcelo Siqueira de Oliveira, et al.
Published: (2015)

The role of prophylactic antibiotics in hepatitis B virus-related acute-on-chronic liver failure patients at risk of bacterial infection: a retrospective study
by: Xiao-Qin Liu, et al.
Published: (2021)

Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
by: Diana N. Vikulova, et al.
Published: (2020)

Dupilumab in atopic dermatitis patients with chronic hepatitis B
by: Masako Matsutani, et al.
Published: (2022)